TAM News 20.30 Taminco Corporation Common Stoc (TAM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Taminco Corporation Common Stoc (TAM) 20.30 $TAM

Taminco Corporation Completes Acquisition Of Formic Acid Business Of Kemira Oyj
PR Newswire - Thu Mar 06, 9:15AM CST
Taminco Corporation (NYSE: TAM), today announced that it has completed the acquisition of the formic acid business of Kemira Oyj. The formic acid business has a global footprint and serves a number of selected markets that are driven by key global megatrends, such as animal nutrition, agriculture, water treatment and energy.

Taminco Corporation Announces Fourth Quarter and Full Year 2013 Results
PR Newswire - Tue Feb 25, 5:00AM CST
Taminco Corporation ("Taminco" or the "Company" (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives for use in the manufacturing of everyday products, today announced results for its fourth quarter and full fiscal year of 2013. Unless otherwise noted, year ago comparisons refer to the three month period and "pro forma" twelve month periods ending December 31, 2012.

Taminco Corporation Announces Fourth Quarter and Full Year 2013 Earnings Release Date and Conference Call
PR Newswire - Fri Feb 07, 11:10AM CST
Taminco Corporation (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives, today announced that the Company will release its fourth quarter and full year 2013 results before the U.S. stock market opens on Tuesday, February 25, 2014, to be followed by a conference call at 8:00 a.m. (Eastern Time).

Taminco Corporation Announces the Repricing of Credit Agreement
PR Newswire - Wed Feb 05, 10:46AM CST
Taminco Corporation (NYSE: TAM) (the "Company" announced today the execution of Amendment No. 3 to the existing Credit Agreement, dated February 15, 2012. The amendment lowered the interest rate on the senior secured facilities by 100bps and increased overall flexibility within the credit agreement. The repricing amendment is expected to reduce the Company's pre-tax annual cash interest payments by approximately $5 million.

Balchem Corporation signs choline chloride JV with Taminco Corporation
M2 - Tue Jan 28, 10:13AM CST
Alkylamine company Taminco Corporation (NYSE:TAM) announced on Monday an agreement to construct a choline chloride facility in St Gabriel, Louisiana with Balchem Corporation (NasdaqGS:BCPC).

Balchem and Taminco Announce a Production Joint Venture for Choline Chloride
GlobeNewswire - Mon Jan 27, 2:54PM CST
Taminco Corporation (NYSE:TAM) and Balchem Corporation (Nasdaq:BCPC) have reached an agreement to build and operate a choline chloride facility in St. Gabriel, Louisiana, where both companies operate existing production facilities. Balchem will contribute its current St. Gabriel choline chloride production assets to the Joint Venture and both parties will invest into expanding these assets into a world scale production unit, which is expected to come on stream in 2015.

Company news for December 24, 2013 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Dec 24, 8:06AM CST
Companies in the News are: STX, XRTX, TAM, MW, JOSB, DIS, TWTR

Taminco Corporation To Enter A New Specialty Chemicals Niche Market - Announces Agreement To Acquire The Formic Acid Business Of Kemira Oyj
PR Newswire - Mon Dec 23, 1:00AM CST
Taminco Corp. (NYSE:TAM), the world's largest producer of alkylamines and alkylamine derivatives, today announced that it has signed a definitive agreement to acquire the formic acid business of Kemira Oyj for a transaction value of approximately EUR 140 (USD 190) million. The formic acid business serves a number of end-markets driven by key global "mega-trends", such as animal nutrition, water treatment and energy. Upon closing, Taminco will acquire a business with EBITDA of approximately EUR 23 (USD 32) million, a manufacturing facility for formic acid and derivatives located in Oulu, Finland, and approximately 160 employees across Finland, the Netherlands, Germany, China, the U.S. and Brazil. The transaction, which has been unanimously approved by the boards of directors of both companies, is expected to close in the first quarter of 2014 and is subject to the fulfillment of customary closing conditions.

3 Stocks Rising on Unusual Volume
at The Street - Thu Dec 12, 6:00AM CST
Unusual volume can signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Taminco Announces Pricing of Secondary Offering of Common Stock
PR Newswire - Wed Dec 11, 5:01PM CST
Taminco Corporation (NYSE: TAM) (the "Company" announced today that the previously announced public secondary offering of 10,000,000 shares of its common stock by certain of the Company's stockholders priced at a price to the public of $20.00 per share (the "Offering". In connection with the Offering, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares. The Offering is expected to close on December 17, 2013, subject to customary closing conditions. All of the shares in the Offering are being offered by selling stockholders. The Company will not receive any of the proceeds from the Offering.

Taminco Commences Proposed Secondary Offering of Common Stock
PR Newswire - Mon Dec 09, 3:27PM CST
Taminco Corporation (NYSE: TAM) announced today that it has commenced a public secondary offering of its common stock (the "Offering". In the Offering, which is subject to market and other conditions, certain of the Company's stockholders intend to offer 10,000,000 shares of common stock for sale and grant the underwriters the right to purchase up to 1,500,000 additional shares from certain of the Company's stockholders. All of the shares in the Offering are being offered by selling stockholders. The Company will not receive any of the proceeds from the Offering.

Taminco Corporation Announces Third Quarter 2013 Results
PR Newswire - Thu Nov 07, 5:00AM CST
Taminco Corporation ("Taminco" or the "Company" (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives for use in the manufacturing of everyday products, today announced results for its third quarter of 2013. Unless otherwise noted, year ago comparisons refer to the three month period and "pro forma" nine month periods ending September 30, 2012.

Taminco Corporation Announces Third Quarter 2013 Earnings Release Date and Conference Call
PR Newswire - Tue Oct 29, 7:30AM CDT
Taminco Corporation (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives, today announced that the Company will release its third quarter 2013 results before the U.S. stock market opens on Thursday, November 7, 2013, to be followed by a conference call at 8:00 a.m. (Eastern Time).

Dow, Taminco Sign Choline Hydroxide Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 13, 10:25AM CDT
Dow AgroSciences LLC, a subsidiary of The Dow Chemical Company, has entered into a strategic supply deal for choline hydroxide with Taminco US Inc., a subsidiary of Taminco Corporation.

Dow AgroSciences signs choline supply agreement with Taminco US Inc
M2 - Tue Aug 13, 5:44AM CDT
Dow AgroSciences LLC reported on Monday the launch of a strategic supply agreement for choline hydroxide with Taminco US Inc for an undisclosed amount.

Taminco Corporation Announces Second Quarter 2013 Results
PR Newswire - Tue Aug 13, 5:00AM CDT
Taminco Corporation ("Taminco" or the "Company" (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives for use in the manufacturing of everyday products, today announced results for its second quarter of 2013. Unless otherwise noted, year ago comparisons refer to the "pro forma" three and six month periods ending June 30, 2012.

Dow AgroSciences, Taminco Announce Choline Supply Agreement
Business Wire - Mon Aug 12, 7:00AM CDT
Dow AgroSciences LLC, a subsidiary of The Dow Chemical Company (NYSE: DOW), and Taminco US Inc., a subsidiary of Taminco Corporation (NYSE:TAM) announce the companies have reached a strategic supply agreement for choline hydroxide. This raw material is a key component of Enlist Duo(TM) herbicide, a highly differentiated herbicide solution specifically designed for the Enlist(TM) Weed Control System. The Enlist system combines innovative traits, herbicides, and stewardship to deliver the weed control that farmers need now while sustaining beneficial farming practices. Under the agreement, Taminco will supply choline hydroxide to Dow AgroSciences for herbicidal uses. Financial terms of the agreement were not disclosed.

Taminco Corporation Announces Second Quarter 2013 Earnings Release Date and Conference Call
PR Newswire - Wed Jul 24, 7:00AM CDT
Taminco Corporation ("Taminco" (NYSE: TAM), the world's largest producer of alkylamines and alkylamine derivatives, today announced that the Company will release its second quarter 2013 results before the U.S. stock market opens on Tuesday, August 13, 2013, to be followed by a conference call at 8:00 a.m. (Eastern Time).

Taminco Corporation to Join Russell 3000® and Russell Global Indexes
PR Newswire - Mon Jul 01, 4:01PM CDT
Taminco Corporation (NYSE: TAM) today announced that it joined the broad-market Russell 3000® and Russell Global Indexes following the Russell Investments reconstitution of its comprehensive set of U.S. and global equity indexes after the U.S. markets closed on June 28, according to a list of additions posted on www.russell.com/indexes.

Taminco Corporation Announces First Quarter 2013 Results
PR Newswire - Tue May 14, 5:00AM CDT
Taminco Corporation ("Taminco" or the "Company" (NYSE: TAM), the world's largest integrated producer of alkylamines and alkylamine derivatives for use in the manufacturing of everyday products, today announced results for its first quarter of 2013.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 350

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 165

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 311

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 213

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 247

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Mary Street Capital: Enhancing Investment Banking Services

Updated Category News Views 300

Mary Street Capital: A New Era in Investment Banking Mary Street Capital has emerged as an innovative investment banking affiliate of Kaufman Rossin, significantly expanding its advisory capabilities. This new venture focuses on addressing the unique needs of family- and founder-owned businesses, particularly those in the middle market that have often felt overlooked by...

Continue Reading
Fluorine-18 Market Growth Driven by Cancer Diagnosis Demand

Updated Category News Views 169

Fluorine-18 Market Growth Context The global fluorine-18 market is on a notable trajectory of growth, anticipated to reach USD 2.54 billion by 2031 from USD 1.85 billion in 2024. This progression is largely influenced by the increasing incidence of cancer and the expanding utilization of nuclear imaging methodologies. The Role of Fluorine-18 in Medical Diagnostics...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 227

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Chargeback Rates Increase Dramatically Amid Visa Changes

Updated Category News Views 320

Surge in Chargebacks Signals Major Industry Changes CLEVELAND — The payments industry is witnessing a seismic shift, with chargebacks soaring by an astonishing 222% year over year. This significant rise has impacted various sectors, including eCommerce, travel, subscription services, and healthcare. Understanding Visa's VAMP Program As Visa introduces its new Acquirer...

Continue Reading